Evidence map›Paper›PMID 36699429›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2023

Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk.

Ana L Basquiera, María A Aguirre, Florencia A Serra, Mayra Vaca, Erika B Brulc, María A Perusini, Gonzalo A Ferini, Natalia P Schutz, Victoria Otero, Damián García Corbanini and 11 more

Open access · greenAbstract read
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Ana L BasquieraHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.ORCID 0000-0001-9892-5543
María A AguirreDepartment of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0001-9690-2284
Florencia A SerraDepartment of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Mayra VacaHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Erika B BrulcHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
María A PerusiniHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Gonzalo A FeriniHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Natalia P SchutzHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Victoria OteroHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Damián García CorbaniniNursery Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Edgardo LitvackNursery Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Julio GironNursery Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Gastón GarnicaNursery Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Bernardo MartinezDepartment of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Hernán MichelangeloDepartment of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Eduardo San RománIntensive Care Unit for Adults, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Javier PollánDepartment of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Dorotea B FantlHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Jorge A ArbelbideHematology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Tte. Gral. Juan Domingo Perón 4190, C1199ABB Buenos Aires, Argentina.
Alejandra ValledorInfectology Section, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
María I StaneloniInfections Committee, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Hospital Italiano de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A program for the hematologic patient at very high risk of infections (HAR, from its initials in Spanish) was implemented, based on a multidisciplinary team and six measures intended to reduce the colonization and subsequent sepsis by multidrug-resistant organisms (MDRO). We aimed at evaluating the effectiveness of the HAR program in terms of MDRO infections mainly caused by

Indexed as

Acute myeloid leukemiaMortalityMultidrug-resistant organismsSepsisStem cell transplantation

Identifiers

PMID36699429
PMCPMC9868195
OpenAlexW3207184167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.